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Abstract 
Purpose: To evaluate the in vitro anti-oxidant and anti-inflammatory potential of the most potent and 
abundant metabolite, 3-methoxy quercetin (3-MQ), from extract fractions of mistletoe, Loranthus 
micranthus Linn (Loranthaceae) parasitic on Kola acuminata Schott & Endl, (Malvaceae), also known as 
Garcinia kola Heckel, (Clusiaceae). 
Methods: Compounds isolated through a combination of chromatographic techniques were screened 
for in vitro antioxidant potential using the diphenyl picrazyl hydrazine (DPPH) radical-based model. Cell 
viability at 1–1000 μM 3-MQ in 24 h was evaluated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) test. Lipopolysaccharide (LPS), phorbol 12-myristate 13-acetate (n = 
5) five (5) replicates. 
Results: Ten (10) known compounds including 3-MQ (1) were isolated and characterized. 3-MQ 
exhibited highly significant (p < 0.05) antioxidant activity with 50 % inhibitory concentration (IC50) of 15.0 
µM; concentrations ≤ 100 μM did not exert cytotoxic effect. 3-MQ, at 25 and 125 µM concentrations, 
significantly (p < 0.05) inhibited the production of TNF-α by 82 and 100 %, respectively, compared to 
controls. 
Conclusion: The results demonstrate the potent anti-inflammatory activity of 3-MQ and suggests its 
use as a potential alternative therapy for inflammation and related diseases. 
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Plant-derived natural products, including the 
quercetin-derivatives, are ubiquitous and 
undoubtedly form interesting scaffolds for the 
development of potent antioxidant-anti-
inflammatory as well as possible antitumor 
congeners. This is illustrated by the fact that in 
the flavonol group alone, over 230 new 
compounds were identified from 1986 to 1992 
[1], while approximately 180 new structures were 
isolated in the subsequent years 2001-2003 [2]. 
The flavonol, quercetin is the most abundant 
specie in nature occurring as rhamnosylated or 
glucosylated derivative [3]. In food, quercetin 
occurs mainly as glycosides and usually, after 
ingestion, derivatives of quercetin are hydrolyzed 
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mostly in the gastrointestinal tract and then 
absorbed and metabolized [4-6]. Therefore, the 
content and form of all quercetin derivatives in 
food is significant for their bioavailability as the 
aglycone. Quercetin as a naturally occurring 
flavonoid protects cells against oxidative stress 
[7,8]. Several studies have shown that quercetin 
in its free or glycosylated form modulates certain 
physiological functions with potent   anti-
proliferative effects in numerous cell lines [9,10], 
pro-apoptotic effect in lung carcinoma cell lines 
[11], and inhibitory effect of bone metabolism 
[12]. 
 
It is well established that the pro-inflammatory 
cytokines, interleukin 1 (IL 1), interleukin 6 (IL 6), 
and tumor necrosis factor (TNF) are involved in 
the regulation of the immune response, 
hematopoiesis, and inflammation. These 
cytokines are actively involved in inflammatory 
responses [13]. Overproduction of reactive 
oxygen and nitrogen species (ROS and RNS, 
respectively) by phagocytes causes oxidative 
damage to membrane lipids, DNA, proteins and 
lipoproteins. These reactions have functional 
consequences, which may be deleterious to cells 
and tissues. Thus, inhibition of ROS and RNS 
production is a popular target for the attenuation 
of many inflammatory diseases [14].  The 
reported anti-inflammatory mechanisms included 
reduction of the pro-inflammatory cytokines IL-6 
and TNF-α, increasing anti-inflammatory IL-10 
secretion, and reduction of cyclooxygenase-2 
(COX-2) and nitric oxide synthase expressions 
[15]. Two excellent reviews of quercetin and 
derivatives with detailed emphasis on their 
structures and functions were published in 2008 
and 2012 [16,17]. Our group investigated and 
reported the osteogenic properties of 3-MQ [18]. 
3-MQ is a derivative of quercetin with an 
attachment of a methoxy group at position 3 of 
quercetin [18]. The present study aims to 
investigate the anti-inflammatory activities of this 
major constituent (3-MQ) of the Nigerian 
mistletoe used traditionally as in the 
management of inflammation and associated 
conditions. The structures of the studied 
compound, 3-MQ alongside nine (9) other co-
isolated compounds as depicted in Figure 1. 
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Epicatechin-o-coumarate (8)  Catechin (9)   Quercetin (10) 
 
Figure 1: Structures of 3-MQ and other isolated compounds 
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Collection of plant materials 
 
Loranthus micranthus leaves parasitic on 
Garcinia kola were collected in October 2011, 
from different locations in Nsukka LGA, Enugu 
state Nigeria. The leaves were identified and 
certified by Mr AO Ozioko, a taxonomist of the 
Bioresources Development and Conservation 
Programme, Nsukka, Nigeria. A voucher 
specimen (no. BDC-1023-011) has been kept at 
the herbarium of the same centre for reference 
purposes.  
 
Materials and reagents for cell cytotoxicity 
and molecular biology studies 
 
The following materials and reagents were 
procured and used for the study: 3-(4, 5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT), lipopolysaccharide, LPS 
(serotype 0128: B 12, L 4255; Sigma, St Louis, 
MO, USA), multi-well plate reader (Bio-Kinetic 
Reader-E312e®; Bio-Tech Instruments, 
Winooski, VT),ELISA kits (R&D Systems, Inc., 
Minneapolis, MN, USA), enhanced luminol 
solution (Pierce Biotechnology Inc. Rockford, IL, 
USA), microplate luminometer (Synergy® H1 
Hybrid Multi-Mode, BioTek Winooski, VT, USA), 
Gen 5 ® version 2.0 (BioTek Winooski, VT, 
USA), Phorbol 12-myristate 13-acetate (PMA), 
RPMI 1640 medium (Corning cellgro® RPMI; 
Mediatech Inc., Manassas, VA, USA), 2-
mercaptoethanol (Gibco, Invitrogen, USA), PBS, 
DMSO. All materials and or reagents were used 
according to manufacturer’s specifications and 
protocols. 
 
Cell lines and culture medium 
 
Laboratory stock of RAW264.7 mouse 
macrophage cell line (ATCC, MD, USA) was 
cultured in R-10 medium, consisting of RPMI 
1640 medium (Corning cellgro® RPMI; 
Mediatech Inc., Manassas, VA, USA) 
supplemented with 10 % heat-FBS, 50 µM 2-
mercaptoethanol (Gibco, Invitrogen, USA), 100 
µg/mL penicillin, and 100 µg/mL streptomycin in 
a 5 % CO2 humidified atmosphere at 37 °C.  
 
Preparation of crude aqueous extract 
 
Leaves of Loranthus micranthus parasitic on 
Garcinia kola were cleansed and dried under 
shade for 8 days. They were pulverized in 
mechanized laboratory grinder to fine powder. A 
total of 1.2 kg of the powdered plant materials 
was macerated repeatedly with distilled water 
(total volume; 12 L, 10 L; 7.5 L respectively). The 
resulting aqueous extracts were lyophilized 
under vacuum affording dry powdered extracts 
which were weighed and their percent yield 
determined. The dry extracts were placed in 
amber-colored glass bottles and stored in a 
refrigerator (4 °C) until use. The yield obtained 
was 9.80 %. 
 
Fractionation of crude extracts of mistletoe 
 
Based on preliminary evaluated anti-
inflammatory potential of different crude extracts 
(unpublished data), exactly 70 g of crude extract 
obtained from mistletoe parasitic on Garcinia 
kola was uniformly dispersed in 450 mL of 
distilled water and then carefully poured into a 
stoppered separatory funnel. Then, aliquots (500 
mL) of analar grade hexane was poured into the 
funnel and vigorously agitated for 5 min to allow 
for equilibration. The funnel was mounted on a 
stand to allow for complete separation of the 
solvents into layers. The lower aqueous layer 
was run off and the upper hexane layer collected 
in a glass bottle. This process was repeated 
severally until the n-hexane no longer extract any 
further constituents from the extract dispersion. 
The hexane fraction was pooled and 
concentrated in vacuo (40 °C) to afford the dry 
hexane fraction. Then, solvents of increasing 
polarity in the order, chloroform<ethyl 
acetate<butanol<water were used accordingly as 
described above for hexane to afford 
corresponding fractions. The major fractions 
were screened for anti-inflammatory activities 
and active fractions subjected to column 
chromatography. 
 
Isolation of 3-MQ (compound 1) 
 
The isolation and characterization of compound 1 
was as previously described [18,19]. 
 
Isolation of other compounds 
 
Compounds 2-10 were isolated using a 
combination of various chromatographic 
techniques. Each time, the separation process 
was monitored by TLC and analytical HPLC. 
Specifically, compounds 2 and 10 were isolated 
from the n-butanol fraction while compounds 3-9 
were from the ethyl acetate fraction. The spectra 
of all compounds were compared to existing 
literature data and were found to be 
unequivocally same. 
 
Vacuum liquid chromatography (VLC) 
 
Exactly 35.4 g of the ethyl acetate (EtOAc) 
fraction was fractionated on a silica gel VLC 
column (200-400 mesh, 20 x 6 cm) using 
Omeje et al 
Trop J Pharm Res, May 2017; 16(5): 1062  
 
gradient elution of n-hexane-EtOAc (100:0, 
90:10, 80:20....0:100 each fraction collected was 
1.2 L), and of dichloromethane in methanol 
(90:10, 70:30, 60:40, 30:70....10:90, each volume 
800 mL) to afford the 15 fractions (F1-F15). The 
fractions of interest, F6-F9 were subjected to 
further VLC sessions and later to sephadex LH20 
column to afford sub-fractions F61, F62, F63, 
F67; F71, F72, F77; F81, F82, F83, F86 and 
F91, F92, F93, F97. The sub-fractions with 
substantial yields were either subjected to semi-
preparative HPLC or sephadex column to obtain 
pure compounds 3-9. This was repeated for the 
n-butanol fraction (22.7 g) to obtain compounds 2 
and 10. Each time, the separation and isolation 





The mobile phase was either HPLC grade 
methanol with nanopure water and with or 
without 0.1 % trifluoro acetic acid (TFA) in 
gradient manner and reverse-phased. The 
maximum quantity of fraction injectable was 3 mg 
in 1ml of methanol. The flow rate was set at 5 
ml/min in the system described thus; pump was 
Merck Hitachi L-7100; detector was also Merck 
Hitachi UV detector L-7400; column was Knauer, 
Berlin, Germany (300 x 8 mm; internal Diameter), 
prepacked with Eurosphere, 100-10 C18, with 
integrated pre-column. 
 
Analytical high performance liquid chromato-
graphy (HPLC) 
 
Analytical HPLC was used to probe the 
distribution of constituents in the extracts and 
fractions and match them with existing 
compound libraries (plants and marine). This 
served to estimate the purity of the isolated 
compound(s) and guide in the choice of isolation 
techniques. The reverse phase gradient flow of 
solvent system was methanol and nanopure 
water in an equilibration pH of 2.0 and run time 
remained 35 min or 60 min depending on 
outcome. The injection volume from an auto 
sampler remained 20 µL with peaks detected by 
an array of UV-Vis photodiode detectors usually 
at 235, 254, 280 and 340 nm wavelength.  The 
complete description of the entire system was as 
follows: Pump-Dionex P580A LPG; detector-
Dionex Photodiode Array Detector UVD 340S; 
Column thermostat-STH 585; Auto sampler- ASI-
100T, HPLC programme used-Chromeleon 
(v.6.3). The instrumentation comprises a pump, 
the detector, injector, separation column and 
solvent reservoir. The column (125 x 2 mm, 
internal diameter) was pre-filled with Eurosphere-
100 C18 of 5 µm pore size. The system had an 
integrated pre-column. 
 
Antioxidant assay of the isolated compounds 
 
All the compounds were assessed for anti-
oxidant potential using DPPH in methanol and at 
a wavelength of 517 nm.  
 
Cell cytotoxicity assay 
 
The effect of 3-MQ on the viability of RAW264.7 
mouse macrophages was determined using a 
modification of the MTT (3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide) 
cytotoxicity assay originally described by 
Mosman [20].  To modify the original MTT assay 
technique, the volumes of reagents and 
temperature of incubation were reduced 
appropriately. 
 
Assessment of inhibition of LPS-induced 
release of nitric oxide by macrophages 
 
Nitric oxide production and release by RAW264.7 
cells was measured indirectly by determining 
nitrite accumulation in culture supernatant using 
the Griess reaction. 
 
Determination of effect of 3-MQ on the 
production of TNF-α 
 
The effect of 3-MQ on LPS-induced release of 
tumour necrosis factor (TNF-α) by macrophages 
was determined according to established 
protocols [21]. 
 
Chemiluminescence determination of ROS 
and RNS scavenging by 3-MQ 
 
Chemiluminescence of RAW264.7 macrophages 
was evaluated in Hank’s balanced salt solution 
(HBSS; pH 7.4) by a modification of the 




Data are expressed as mean  SEM. The data 
obtained in experiments with multiple treatments 
were subjected to one-way ANOVA followed by 
Newman-Keuls post-hoc multiple comparism test 
using Prism 3.0 version software.  Where 
necessary, Student’s ‘t’ test was used to study 
statistical significance (p<0.05) in experiments 
with only two treatments. 
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Antioxidant activity of the compounds 
 
Out of the ten compounds tested (Figure 1), 
compound 1 (3-MQ) exhibited highly significant 
(p<0.05) antioxidant activity compared to the 
controls (Table 1). This further informed its 
choice for further detailed anti-inflammatory 
research work. 
 
Table 1: Radical scavenging activity of isolated 





1 89.9 ± 1.00 15.00 
2 69.0 ± 1.00 35.00 
3 72.5 ± 2.50 29.00 
4 70.0 ± 2.70 25.00 
5 65.0 ± 3.90 38.50 
6 60.0 ± 3.70 39.70 
7 61.0 ± 4.20 40.00 
8 66.0 ± 5.60 36.80 
9 70.0 ± 4.60 28.20 
10 72.0 ± 4.10 24.00 
Ascorbic acid 94.8 ± 4.70  7.50 
Chlorogenic acid 98.9 ± 1.20  4.50 
Compound 1 (3-MQ) exhibited the highest radical 
scavenging activity 
 
Effect of 3-MQ on cell viability 
 
The effect of 3-MQ on the viability of RAW 264.7 
cells is shown in Figure 2. The compound, 
beyond a concentration of100 µg/mL caused a 
sharp reduction in the number of viable cells. 
However, the high concentration of compound 




Figure 2: Effect of 3-MQ on viability of RAW 
264.7 cells 
 
Effect of 3-MQ on nitrite production by RAW 
264.7 cells 
 
3-MQ significantly caused a dose-dependent 
reduction in the amount nitrite produced by the 
RAW 264.7 cells compared with both controls. 3-
MQ caused a graded inhibitory response on the 
production of nitric oxide by the RAW 264.7 cells 
(Figure 3). This suggests the potential anti-
inflammatory activity of the compound. 
 
Inhibitory effect of 3-MQ on tumour necrotic 
factor (TNF-α) production 
 
The compound, 3-MQ caused a dose-dependent 
graded inhibitory response on the production of 
TNF-α by the RAW 264.7 cells (Figure 4). This 
suggests significant potential anti-tumor and anti-
inflammatory activity of the compound. 
 
 
    Figure 3: Effect of 3-MQ on nitrite production by RAW 264.7 cells 
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                   Figure 4: Effect of 3-MQ on the production of TNF-α 
 
 
Figure 5: Effect of 3-MQ on chemiluminescence of PMA-activated RAW264.7 macrophages cells 
 
Effect of 3-MQ on chemiluminescence of PMA 
activated RAW264.7 macrophages cells 
 
The compound, 3-MQ significantly inhibited 
chemiluminescence of PMA activated RAW 
264.7 macrophage cells in a dose-dependent 
manner (Figure 5). This suggests that the 




The present study shows that the Eastern 
Nigeria mistletoe extract is rich in flavonoids and 
related polyphenols. These compounds showed 
moderate to highly significant antioxidant 
activities with 3-MQ as the most potent (Table 1). 
It is well known that inflammation is significantly 
correlated with oxidative stress and hence 
compounds with potent radical scavenging 
activity are probable candidates for anti-
inflammatory or antitumor screening. Coupled 
with the presence of gallic acid and its 
derivatives in high concentration, mistletoe 
extracts has justification for its many 
ethnomedicinal uses as anti-inflammatory, anti-
rheumatic, antimicrobial and antihypertensive 
agent [18]. In response, an attempt was made to 
study the cytotoxic effects and the anti-
inflammatory properties of 3-MQ, obtained in 
very high amount from the extract. 
 
The cytotoxicity profile for 3-MQ revealed no 
significant cytotoxic effects at concentrations of 
0, 5, 25 100 µg/mL. However, toxicity was 
observed at concentrations of 250, 500 and 1000 
µg/mL. The observed toxicity on the RAW 264.7 
cells was dose-dependent. Higher concentrations 
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of 3-MQ (>1000 µg/mL) were toxic to the cells. In 
contrast, Yen-Chou et al [22] reported a 
concentration-dependent inhibitory effects of 
quercetin and its pentaacetate derivative, on 
LPD-induced NO production in without obvious 
cytotoxic effect on the RAW 264.7 cells. 
 
Expectedly, the methoxy group at position 3 of 
quercetin moiety which enhances lipophilicity of 
the molecule (increased cellular permeation by 
the compound) could probably be responsible for 
this observed toxicity at much higher doses. It is 
therefore, reasonable, to use optimal doses of 3-
MQ that will elicit the required biological activity 
without precipitating toxicity. Although nitric oxide 
exerts anti-inflammatory effect under normal 
physiological conditions, it is considered as a 
pro-inflammatory mediator that induces 
inflammation due to excessive production in 
abnormal conditions. Lipopolysaccharide (LPS)-
challenged RAW 264.7 cells, which have not 
been pre-treated with 3-MQ, resulted in 
excessive production of nitric oxide (NO).  
 
There was a dose-dependent reduction in the 
production and release of NO for the cells pre-
treated with 3-MQ. Specifically, when compared 
to the positive control group (group without LPS), 
there was inhibition of NO release at 
concentrations of 25 and 125 µM of 3-MQ. At 
125 µM, 3-MQ almost restored the concentration 
of NO under normal physiological conditions 
(94.88 % reduction). This finding corroborate an 
earlier report that flavonoids and their glycosides, 
such as apigenin, wogonin, luteolin, tectorigenin, 
and quercetin inhibited NO production in LPS-
activated RAW 264.7 cells as measured by nitrite 
formation at 10-100 µM [23]. This finding 
supported an earlier report by Luo et al [24] who 
found that quercetin and hyperoside exhibited 
concentration-dependent enzyme inhibitory 
effects on NO production in activated 
cells. Although further mechanistic studies are 
required to understand the possible pathway of 
action,  it is  plausible to propose a mechanism 
for this observed activity, possibly due to 
reduction of induced nitric oxide synthase (iNOS) 
enzyme expression since nitric oxide (NO) 
produced by inducible iNOS is one of the 
inflammatory mediators. 
 
There was excessive production of TNF-α by the 
lipopolysaccharide-activated RAW 264.7 cells. 
TNF-α is a pro-inflammatory cytokine, and hence 
its presence in an abnormal concentration 
signals inflammation. It was observed that 3-MQ 
pre-treated RAW 264.7 cells suppressed the 
production of the pro-inflammatory agent; TNF-α. 
This inhibition was observed to be dose-
dependent, with maximum inhibition occurring at 
the 125 µM concentration of 3-MQ. This 
inhibitory activity is comparable to the positive 
control group (group without LPS). Therefore, 3-
MQ was able to restore the normal production of 
TNF-α by the RAW 264.7 cells when activated by 
the LPS.  A previous study reported several anti-
inflammatory mechanisms to include reduction of 
the pro-inflammatory cytokines IL-6 and TNF-a, 
increasing anti-inflammatory IL-10 secretion, as 
well as reduction of cyclooxygenase-2 (COX-2) 
and nitric oxide synthase expression [15]. 
 
Regarding the anti-inflammatory property, ROS 
and RNS release by activated RAW264.7 cells 
was significantly inhibited by 3-MQ.p<0.05  
Inflammation processes trigger off reactions 
between macrophages  and microorganisms 
leading to the excess production of mediators 
such as reactive oxygen species (ROS) and 
nitrogen species (RNS), nitric oxide (NO), as well 
as  various cytokines. Oxidants and nitrogenous 
compounds generated by macrophages to 
destroy phagocytized pathogens are also 
involved in tissues injury associated with 
inflammatory process [25].  Numerous studies 
have found out that phenolic acids and 
flavonoids, which are biologically active 
molecules, act as scavengers of free radicals 
and inhibitors of nitric oxide and inflammatory 
cytokines production by macrophages and/or 
neutrophils. 3-MQ, a flavonoid, exerts anti-
inflammatory properties by inhibiting 
chemiluminescence reactions and scavenging 




The observed reduction in the pro-inflammation 
agents (NO and TNF-α) and the radical 
scavenging activity against ROS and RNS in 
LPS-stimulated RAW 264.7 cells in a dose-
dependent manner is an indication of the anti-
inflammatory activity of 3-methoxy quercetin. The 
cytotoxicity of higher doses of 3-MQ needs to be 
further investigated. In addition, mechanistic 
studies on this compound would be helpful in 
view of its in vitro anti-inflammatory activity 
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